compound 15 [PMID: 35450354]   Click here for help

GtoPdb Ligand ID: 11989

Compound class: Synthetic organic
Comment: This compound is a dual Toll-like receptor 7/8 antagonist [1]. It produces predicted pharmacodynamic effect (inhibition of TLR7-dependent IFNα release) in vivo following oral administration.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 56.84
Molecular weight 393.23
XLogP 5.04
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1CC[C@H]([C@@H](C1)F)Nc1n[nH]c2c1cc(C1CC1)c(c2)c1cc(C)nc(c1)C
Isomeric SMILES C1(CC1)c1cc2c(n[nH]c2cc1c1cc(nc(c1)C)C)N[C@H]1[C@@H](CN(CC1)C)F
InChI InChI=1S/C23H28FN5/c1-13-8-16(9-14(2)25-13)18-11-22-19(10-17(18)15-4-5-15)23(28-27-22)26-21-6-7-29(3)12-20(21)24/h8-11,15,20-21H,4-7,12H2,1-3H3,(H2,26,27,28)/t20-,21-/m1/s1
InChI Key PNGWZDXPZBZBRC-NHCUHLMSSA-N
Bioactivity Comments
In vitro, compound 15 inhibits TLR8-mediated TNFα release in whole blood (induced by ssRNA TLR activation) with an IC50 of 0.6 nM, and inhibits TLR7-mediated IFNα release in whole blood with an IC50 of 4.9 nM[1]. It exhibits good selectivity for TLRs 7 and 8 compared to TLRs 4 and 9.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
TLR8 Hs Antagonist Antagonist 8.7 pIC50 - 1
pIC50 8.7 (IC50 2x10-9 M) [1]
Description: Binding determined in a FRET assay